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Abstract
The anthropometric status and metabolic control of 51 recently diag-
nosed Brazilian schoolchildren with type 1 diabetes (DM1), during the
first 5 years of the disease, were compared with those of normal
children (60 girls and 132 boys) belonging to the same environmental
condition and pubertal stage. Metabolic control was evaluated on the
basis of fasting plasma glucose (FPG) and HbA1c levels. The criteria
of the National Center for Health Statistics were used for anthropo-
metric evaluation. FPG (205 – 51 mg/dl for girls vs 200 – 34 mg/dl for
boys) and % above upper normal limit of median HbA1c (1.8% for
girls vs 2.5% for boys with diabetes) were not significantly different
during follow-up. The Z-score of the last height evaluation was lower
in the girls group (-0.14 vs -0.53, P<0.05). By forward stepwise
analysis, the Z-score of the initial height was statistically significant as
a determinant factor for height at the end of the study in both girls and
boys with DM1. The Z-score of weight at last evaluation was not
different from that at diagnosis in either sex. However, analysis
according to pubertal stage showed a tendency to a weight increase in
the girls. The weight recovery and height loss in girls with DM1
follows the trend of the normal Brazilian population.
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Introduction
Normal growth and development, in ad-
dition to the prevention of chronic diabetic
complications, are the main goals in the man-
agement of children and adolescents with
diabetes mellitus. Growth rate and develop-
ment studies of these individuals are contro-
versial (1-4). Some studies reported that chil-
dren at type 1 diabetes mellitus (DM1) diag-
nosis may present increased (2,5-7), normal
(8,9) or low (1,10) height. These data sug-
gest that clinically silent endocrine and meta-
bolic alterations (7,10-12) can modify the
growth and development of these patients
before the first clinical signs of this disease
are observed.
Studies performed in order to evaluate
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the effect of insulin deficiency and meta-
bolic control on the somatic and sexual de-
velopment of diabetic children have consid-
ered mainly age, gender and presence or
absence of pubertal signs (13,14). Besides
the effect of metabolic control on the growth
and development of diabetic children, envi-
ronmental conditions and pubertal stage at
diagnosis or in the first years of the disease
could be significant factors to be considered.
Thus, it is necessary to compare diabetic and
normal children belonging to the same envi-
ronment, growth stage and pubertal devel-
opment. So the major problem in growth
studies is the choice of adequate reference
data. There is a lack of studies within this
context in Latin American children. The aim
of the present study was to examine the
weight and height of Brazilian children and
adolescents at DM1 diagnosis and after the
first 5 years of conventional insulin therapy.
We compared these patients to normal chil-
dren belonging to the same environmental
conditions and pubertal stage.
Subjects and Methods
Subjects
Fifty-one children and adolescents (24
girls: median age = 10.9 years and 27 boys:
10.6 years at different pubertal stages) with
an early diagnosis (less than 6 months) of
type 1 diabetes were recruited for this study,
which was approved by the Institutional Eth-
ics Committee of Hospital Sªo Paulo, Escola
Paulista de Medicina, UNIFESP, Sªo Paulo,
SP, Brazil. The diagnosis of type 1 diabetes
was defined according to the criteria estab-
lished by the National Diabetes Data Group
(15). Exclusion criteria were the presence of
any other abnormalities such as hormonal,
renal, respiratory, gastrointestinal or hema-
tological diseases and pathologic short stat-
ure. The patients were evaluated at 3-month
intervals from diagnosis to the end of the
study.
These patients were compared with a
group of 192 healthy schoolchildren regard-
ing chronological age, gender and pubertal
development using an equation for adjust-
ment (see below).
Auxology and puberty
Anthropometric determinations were re-
corded on the occasion of each patients
consultation. The individuals were evalu-
ated wearing minimal clothes and without
shoes. Weight was obtained using a conven-
tional scale with a precision of 100 g. Height
was measured in the orthostatic position
using a conventional anthropometer. Body
mass index (BMI, kg/m2) was calculated as
weight (kg) divided by square height (m2)
(16).
The pubertal development stage was re-
corded by the same physician (F.V.T.) ac-
cording to development of breasts (B) in
girls and genitals (G) in boys according to
the method of Marshall and Tanner (17,18).
Breast development and menarche were re-
corded for girls and testicular volume was
measured in boys using a Prader orchidom-
eter. The beginning of breast development
and the increase in testicular volume above 3
ml were taken as definite signs of pubertal
onset.
The criteria of the National Center for
Health Statistics (NCHS) (19) were followed
for anthropometric evaluation. The weight
and height 50th percentiles were the criteria
used for the calculations of the respective Z-
scores (19). The Z-score formula is:
Z-score (*) = individual value - mean of reference standard for chronological age (CA)
SD of populational reference standard for CA
(*): height or weight
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The height (m), weight (kg), BMI (kg/
m2) and the Tanner stages of these patients
were recorded at the beginning and the end
of a mixed longitudinal and cross-sectional
study.
The patients were compared with a local
sample (60 girls and 132 boys between the
5th and 95th percentile for height and weight)
of the same socioeconomic level and their
anthropometric evaluation was related to both
chronological and bone age and known hor-
monal levels (estrogen for girls and testos-
terone for boys). From this sample, adjust-
ment equations YH or YW = A + B X were
obtained, in which YH represents the height
adjusted to chronological age and pubertal
stage, YW represents the weight adjusted to
age and pubertal stage, X represents the
chronological age in years for each pubertal
stage from B1 to B4 + B5 in girls and G1 to
G5 in boys (20,21), and A and B are adjust-
ment constants (Table 1).
Height was considered normal for age
when above -1 Z-score.
Mild stunting was defined in children
with height for age below -1.4 Z-score
(equivalent to <93% of the median of the
NCHS reference; 19), calculated using the
ANTRHO program (20) but with normal
weight for height (– 1 Z-score or 90-110%).
Assessment of glycemic control
The metabolic control of these patients
was measured by means of fasting plasma
glucose (FPG, mg/dl) and glycohemoglobin
(% HbA1c), evaluated during the study pe-
riod. Twelve FPG and four HbA1c determi-
nations were made for each patient. Fasting
venous blood glucose samples were collected
8-12 h after the last meal and glucose levels
were obtained by the glucose oxidase method
(normal values ranging from 70 to 110 mg/
dl). The HbA1c values above the upper nor-
mal limit (% AUNL HbA1c) were used as a
comparative score in order to analyze the
HbA1c values determined by each method.
Therefore, % AUNL HbA1c = HbA1c val-
ues - upper normal limit of that specific
method. The methods used to determine
HbA1c levels were: affinity chromatogra-
phy I (upper normal limit = 5.3%), affinity
chromatography II (upper normal limit =
8.0%) and ion-exchange chromatography
(upper normal limit = 8.5%).
Treatment
A mixture of intermediate (NPH) and
rapid (regular) insulin was administered at
least twice daily. Insulin dose was adjusted
according to clinical and metabolic control
parameters.
Statistical analysis
All data are reported as means – SD
unless otherwise stated. Differences between
Table 1. Equations of height and weight adjustments to chronological age (years) at each sexual maturation
stage of girls and boys of the present study.
Girls (N = 60) Boys (N = 132)
Height Weight Height Weight
B1: YH = 75.8 + 6.6 X YW = 4.0 + 3.1 X G1: YH = 101.0 + 3.6 X Yw = 7.7 + 2.3 X
B2: YH = 85.9 + 5.1 X YW = 1.7 + 3.1 X G2: YH = 122.9 + 2.2 X YW = 38.8 + 0.2 X
B3: YH = 86.3 + 5.0 X YW = 10.0 + 2.2 X G3: YH = 93.7 + 4.7 X YW = 17.4 + 1.9 X
B4 + B5: YH = 111.0 + 3.2 X YW = 28.2 + 1.3 X G4: YH = 108.4 + 3.8 X YW = 11.3 + 2.9 X
G5: YH = 123.6 + 3.0 X YW = -1.8 + 3.9 X
B1-B5 = breast; G1-G5 = genital development according to the Tanner scale. YH or YW = height  or weight
adjusted for age and pubertal age. X = chronological age in years.
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groups were analyzed by the Mann-Whitney,
Kruskal-Wallis or Wilcoxon rank-sum tests.
Multiple stepwise regression analysis was
used to identify factors exerting independent
effects on final height, and Z-score using
chronological age, pubertal stage, fasting
plasma glucose, HbA1c and daily insulin
dose as linear variables. Statistical signifi-
cance was set at P£0.05.
Results
Diabetic ketoacidosis was present at di-
agnosis in 12/24 (50.0%) girls and 11/27
(40.7%) boys. On that occasion, blood glu-
cose was 502 – 270 mg/dl (mean – SD) in the
girls group and 562 – 189 mg/dl in the boys
group (not significant).
At the beginning of the study no signifi-
cant differences were found between girls
and boys regarding any of the parameters
analyzed (chronological age, prepubertal
stage percentage, period after diagnosis,
height and weight Z-scores, Y-control for
both height and weight, or BMI), as shown in
Table 2.
At diagnosis, girls were between the 5th
and 95th percentile regarding weight and
between the 2.5th and 95th percentile re-
garding height, according to NCHS stan-
dards. Among the boys, three (11%) were in
the prepubertal stage. These three patients
were below the 5th percentile regarding
weight and one of them also presented mild
stunting characteristics.
When the diabetic children were com-
pared with pubertal controls, both girls and
boys were distributed equally around the Y-
parameter regarding height (Figure 1A
(initial) and B (final) for girls and Figure
2A and B initial and final, respectively, for
boys) and weight. The Z-scores of these
measurements were not significantly differ-
ent among the groups studied at the begin-
ning of the survey (Figure 3).
At the final evaluation, the duration of
diabetes was similar for girls (3.5 – 1.4
years) and boys (3.9 – 1.2 years). BMI (girls:
20 – 3.0 kg/m2 vs boys: 18.6 – 2.3 kg/m2),
FPG (girls: 205 – 34 mg/dl, N = 11 samples,
Table 2. Clinical characteristics of children with type 1 diabetes mellitus at diagnosis and at the end of
follow-up.
Girls (N = 24) Boys (N = 27)
Initial Final Initial Final
Age (median [range], years) 11 [5.4-15.6] 14.4 [7.8-16.8] 10.6 [5.7-13.9] 13.8 [8.4-17.8]
Prepuberal, N (%) 10 (41.7) 4 (16.7) 19 (70.3) 7 (25)
Time from diagnosis# 27 ± 47 days 3.5 ± 1.4 years 67 ± 71 days 4.0 ± 1.1 years
Height (cm)# 137.5 ± 15.9 150.4 ± 12.7 137 ± 15.4 155.3 ± 16.0
Z-score -0.14 -0.53* -0.29 -0.48
Y-control for height
Above, N (%) 10 (42.0) 7 (29.2) 7 (25.9) 8 (29.6)
Equal, N (%) 6 (25.0) 3 (12.5) 4 (14.8) 5 (18.5)
Below, N (%) 8 (33.3) 14 (58.3) 16 (59.3) 14 (51.8)
Weight (kg)# 32 ± 12 45.8 ± 13.5 32 ± 9.6 46.1 ± 14.1
Z-score -0.03 -0.02 -0.21 -0.34
Y-control for weight
Above, N (%) 9 (37.5) 14 (58.2) 8 (29.6) 7 (25.9)
Equal, N (%) 2 (8.3) 3 (12.3) 1 (3.7) 0
Below, N (%) 13 (54.2) 7 (29.2) 18 (66.7) 20 (74.1)
BMI (kg/m2)# 17 ± 3 20 ± 3 16 ± 2 18 ± 2
#Data are reported as means ± SD. N (%) = number (percentage).
*P<0.05 compared to the initial value (Mann-Whitney test).
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vs boys: 200 – 51 mg/dl, N = 12 samples),
HbA1c (% AUNL) (girls: 1.8 – 1.3%, N = 4
samples, vs boys: 2.5 – 1.6%, N = 3 samples),
and insulin dose (U kg-1 day-1) (girls: 0.88 –
0.27 vs boys: 0.80 – 0.24) were also similar.
These parameters were not statistically dif-
ferent between girls and boys.
Concerning girls weight at final evalua-
tion, two (8.3%) of them were below the 5th
percentile and none was obese according to
NCHS standards. However, 14 girls (58.2%)
were overweight when compared with the
pubertal control group. In relation to NCHS,
height was impaired in 16 (66.7%) girls and
14 (58.2%) were below the respective pu-
bertal Z-score control at the final evaluation
(Figure 3).
Twenty boys (74.1%) presented weight
below the respective pubertal control at final
evaluation. Regarding boys height, seven
(26%) who were G1 or G2 at diagnosis,
evolved to below or equal to the 5th percen-
tile. A comparison of diabetic boys with
their pubertal control group showed that 14
(51.8%) were below the respective Y-height
parameter at final evaluation.
The daily insulin dose did not show a
correlation with BMI in either gender during
treatment. Among prepubertal girls and boys
at diagnosis, 6/10 (60%) and 8/19 (42%)
evolved to Tanners stage II at the chrono-
logical age of 10.6 – 1.2 years and 12.3 – 1.3
years, respectively. Menarche occurred at
age of 13 – 0.7 years in eight girls.
Multiple stepwise regression analysis was
used to identify factors exerting independent
effects on height at final evaluation: chrono-
logical age, pubertal stage, initial (height,
weight and BMI) and final (weight) anthro-
pometric measurements, and metabolic pa-
rameter.
HbA1c measured during follow-up and
daily dose of insulin were considered inde-
pendent variables, whereas final height and
Z-score of the final height were considered
dependent variables. These analyses were
performed in the total group (51 diabetic
Figure 1. Height in relation to age and pubertal stage (Tanner’s classification; B1 to B4 + B5)
at diagnosis (A) and at final evaluation (B) in type 1 diabetic girls. B1-B5: breast develop-
ment.
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Figure 2. Height in relation to age and pubertal stage (Tanner’s classification; G1 to G4 + G5)
at diagnosis (A) and at final evaluation (B) in type 1 diabetic boys. G1-G5: genital develop-
ment.
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children) and in the gender subgroups (24
girls and 27 boys) separately. In the whole
group the final height could be predicted by
the combination of chronological age (initial
and final) and initial height. In the girls
group the final height could be predicted by
initial height and final pubertal stage. Height
of diabetic boys at final evaluation could be
predicted by initial chronological age and
height and by pubertal stage (initial and fi-
nal). These analyses showed that the Z-score
of initial height is a factor that may affect
final height in the whole diabetic group and
also the girls and boys subgroups.
Discussion
In this study, the development and growth
of diabetic children during approximately
the first 5 years of disease were evaluated
and compared with normal individuals
matched to each pubertal stage. Weight and
height were studied by a Y-parameter de-
fined across the slope of the straight line
(Table 1). This parameter varies according
to age for each breast development stage for
girls (17) and genital stage for boys (18). By
comparing the diabetic group with pubertal
control groups it was possible to evaluate the
anthropometric development characteristics
and to correct age and stage of sexual devel-
opment at each time investigated.
The height standard deviation score was
lower than zero (the normal population me-
dian) in our diabetic patients at diagnosis.
This finding agrees with those reported by
Emerson and Savage (9) and partially con-
firms the data of Hauane (22) and Hoskins et
al. (1). When the present data were corrected
for pubertal stage and age a uniform distri-
bution around the Y-parameter was found
for female (Figure 1A) and male (Figure 2A)
diabetic patients, indicating that puberty
evolved as expected.
Signs of mild stunting and low stature
were already present at the first evaluation in
11% of the boys group, when most of them
were prepubertal (G1) or early pubertal (G2).
Bognetti et al. (7), studying a group of dia-
betics younger than ours, found that, at onset
of diabetes, they were taller for their age and
sex compared to nondiabetic subjects.
It is known that the male adult Brazilian
population is approximately 7 cm shorter
than the NCHS standard (23). According to
the analysis of these data of the National
Food and Nutritional Institute, Brasília, DF,
Brazil, this final height loss is due to a gradual
process starting during the second year of
life and becoming more evident from 10 to
15 years of age, which in this stage coincides
with the age of the male patients in stages G1
and G2 of pubertal development at DM1
diagnosis. Since most (70.3%) of the DM1
boys were prepubertal at diagnosis with a
median age of 10.6 years (range: 5.7 to 13.9
years), it is possible that these conditions
increased the effect of negative determinants
for height at first evaluation. One of these
determinants in DM1 patients may be the
preclinic metabolic alteration potentiating
the effects of irregular nutrition on growth
rate.
The Z-score of NCHS weight at diabetes
diagnosis was negative, but close to zero, for
both genders, corresponding to what was
found in another study (7). This weight cor-
rected for age and pubertal stage was below
Z-
sc
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0
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Figure 3. Weight and height Z-score at diagnosis and at final evaluation in type 1 diabetic
girls (A) and boys (B).
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normal in most children. This is probably a
result of relative insulinopenic periods which
precede the diagnosis of diabetes (24).
When FPG and HbA1c levels above nor-
mal and exogenous insulin (U kg-1 day-1)
were compared during follow-up, no statisti-
cally significant differences regarding sex or
pubertal stage were found. It is known that
there is a 40-50% increase in insulin require-
ments during puberty. In general, the total
daily insulin dose for these patients is ap-
proximately 1 to 1.5 U/kg body weight. We
can observe that both in the boys (0.80 –
0.24 U kg-1 day-1) and girls (0.88 – 0.27 U
kg-1 day-1) groups, the insulin dose was al-
most a half that amount. Bognetti et al. (7)
used a lower insulin dose (0.69 – 0.22
U kg-1 day-1) for their late pubertal patients
than that used in our study. They also found
a linear growth decrease during the first
years of the disease. Therefore, this can be
one of the factors which contribute to reduc-
ing height recovery in both diabetic girls and
boys. Zachrisson et al. (25) have shown the
importance of sufficient exogenous insulin
supplement during the period of rapid linear
growth in diabetic children (26).
Danne et al. (27) have shown that even
modest alterations in metabolic control can
lead to a lower final height in patients with
diabetes. In the present study with HbA1c
around 1.8 to 2.5% above normal levels, no
height recovery was observed in boys or
girls during follow-up.
It is known that final height also reflects
nutritional status and consequently the so-
cioeconomic conditions of our country (23).
The effects of these factors are different
regarding sex as reported by large popula-
tion (23) and local (28,29) studies. These
studies also show the importance of a special
treatment of anthropometric data according
to sex. Although children of both genders
were equally distributed around the respec-
tive Y-parameter for weight and height in the
follow-up, these parameters presented some
peculiarities in diabetic girls. In the final
evaluation, the weight of these girls was
equally distributed around the 50th NCHS
percentile, but when adjusted to pubertal
stage, 58.2% of the girls were overweight
(Table 2).
The weight gain in diabetic girls, particu-
larly at the end of puberty, may impair some-
what compliance with treatment because
there is the tendency to relegate it in an
attempt to slim (4). Concerning the absence
of a correlation between daily insulin dose
and weight, alterations in the eating habits
and individual changes in physical activities
are not sufficient to explain overweight in
girls (30,31). Veiga and Sigulen (28), in
Brazil, observed an increase in the preva-
lence of obesity in female adolescents of low
socioeconomic level and emphasized the
importance of correcting weight for height
in the nutritional evaluation. This observa-
tion, taking into account weight adjustment
for age corrected by the Y-parameter for
pubertal stage, was also sensitive in detect-
ing overweight in DM1 girls.
The diabetic girls evolved with signifi-
cant stature impairment as indicated by the
behavior of the respective Z-scores (Figure
3). The impaired final stature of diabetic
children has been reported since the classi-
cal study by Tatterssal and Pyke (32) on
identical twins. Clarke et al. (33), evaluating
children according to pubertal development,
demonstrated a higher vulnerability to meta-
bolic disorders resulting from hyperglyce-
mia in the prepubertal stage. However, this
was not observed in our patients during the
study period, with the same level of meta-
bolic control in the prepubertal (girls: HbA1c
(% AUNL): 2.05 – 1.29, boys: 2.67 – 1.76)
and pubertal (girls: 1.79 – 1.37, boys: 2.50 –
1.61) stage as demonstrated by the HbA1c
values.
Since all girls evolved to pubertal stages
(Figure 1A and B) and had their menarche at
the expected ages (23), precocious puberty
can be excluded as being responsible for
stature impairment. Eighteen girls reached
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advanced stages (B3, B4 + B5) of sexual
development during the observation period,
and 11 (61%) of them were below the puber-
tal control regarding height, suggesting re-
duction of the growth spurt. Although weight
calls less attention than stature, regarding
the effect of DM1 on child development,
there are reports of a tendency to obesity
among diabetic girls during puberty (10,34).
Alerted by the frequency of overweight in
girls, we may assume that inadequate meta-
bolic control, associated or not with former
malnutrition, led to growth deficit and weight
recoveries above those corresponding to their
pubertal stage, similar to the nutritional re-
covery already studied in girls attending pub-
lic schools (29).
Finally, multiple stepwise regression anal-
ysis showed that Z-score of the initial height
is a more important factor for height after 4
to 5 years of follow-up both in the diabetic
group as a whole and in the subgroups of
girls and boys with diabetes.
In view of the impossibility to study the
genetic potential for growth in the present
patients, and considering the nutritional sta-
tus and socioeconomic conditions of the Bra-
zilian low-income population in general (23),
we may assume that onset of DM1 during
early pubertal stages in the boys was an
additional factor of growth failure.
In conclusion, at diagnosis of the disease,
Brazilian children and adolescents with DM1
have a lower but not significantly different
weight and height when compared to non-
diabetic subjects matched for age and puber-
tal stage and environmental conditions. In
the first 4-5 years of disease girls tended to
recover weight and showed a linear growth
decrease. Boys evolved with low weight and
did not reach a positive Z-score regarding
height. Girls and boys with DM1 presented
normal pubertal development. The age, height
and pubertal stage when diabetes is diag-
nosed may have a positive effect on height
development. The tendency to weight recov-
ery and low height in diabetic girls follows
the tendency of the normal Brazilian popula-
tion.
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